ISOThrive
Manufacturing · Virginia, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
11100 Endeavor Ct, Manassas, Virginia, 2...Phone Number
(855) 552-5572Website
www.isothrive.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
2
2
1
1
1
1
About ISOThrive
ISOThrive Inc. is a clinical stage biotech company focused on microbiome therapeutics aimed at treating chronic diseases caused by microbiome dysbiosis. They develop proprietary digestion-resistant carbohydrates, specifically maltosyl-isomaltooligosaccharide (MIMO), to target beneficial bacteria and correct dysbiosis. Their lead asset, ISOT-101, is currently in a phase 2 study, with initial indications including GERD, IBS-C, and functional dyspepsia. The company utilizes advanced platforms for rapid carbohydrate drug discovery and precision medicine to create tailored therapeutic solutions for gastrointestinal conditions.Explore more
ISOThrive Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is ISOThrive your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
ISOThrive, which may be a good buyer, showed buying intent in Masked Content Topic
Click to see if ISOThrive had a recent Job posting/layoffs
Earning: See what the market has to say on ISOThrive recently announced quarterly report
Congratulate Masked Content for being promoted to Masked Content at ISOThrive
Funding: Get notified immidiatlly once ISOThrive has new funding data
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Website visits: Recent activity has been detected on your website
Check out if ISOThrive is spiking on competitors!
Product Launch: Get notified when ISOThrive launches new products
Check if ISOThrive has recently received funding, and reach out quickly before it becomes old news!
Recommended Actions
Find VP level buyers at ISOThrive
Find 2 more new buyers
Compare Similar Companies to ISOThrive
Compare insights from companies similar to ISOThrive, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
ISOThrive is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
ISOThrive is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about ISOThrive.
ISOThrive financials insights
Gather financial insights about ISOThrive, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2014
Unspecified
$1.4M
ISOThrive Tech Stack
A closer look at the technologies used by ISOThrive
See more technologies
ISOThrive News & Media
ISOThrive Awarded Composition of Matter and Production Method Patent for its First "Farmaceutical™" to Support Animal Health
HEALDSBURG, Calif., Aug. 31, 2021 /PRNewswire/ -- ISOThrive Inc., a microbiome therapeutics company announced today that the U.S. Patent and Trademark Office has issued a Composition of Matter and Production Method patent for its first Farmaceutical™ Maltosyl-Isomaltooligosaccharides...ISOThrive Awarded $800K Virginia Catalyst Grant to address major unmet need in gastroesophageal reflux disease (GERD) treatment and drive economic growth in Virginia
HEALDSBURG, Calif., Oct. 26, 2020 /PRNewswire/ -- ISOThrive Inc. has been awarded $800,000 from Virginia Catalyst to advance its microbiome therapeutic for Gastroesophageal Reflux Disease (GERD). The funding will support a Phase 2A clinical study in collaboration with Eastern VA Medical...ISOThrive Announces New Key Executive Appointments
ISOThrive Inc, a microbiome therapeutics company, announced today it has filled three key positions.ISOThrive's Novel Microbiome-Inspired GERD Therapeutic Begins FDA Drug Approval Path
HEALDSBURG, Calif., April 23, 2019 /PRNewswire/ -- ISOThrive LLC, a microbiome-inspired therapeutics development company announced today it has begun the process to achieve FDA drug approval of its patented bacterial microFood™ product for Gastroesophageal Reflux Disease (GERD). A $14B...
Read more news
Top Manufacturing Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding ISOThrive
Sign Up For FreeTo access detailed company insights
ISOThrive Inc. is a clinical stage biotech company focused on microbiome therapeutics aimed at treating chronic diseases caused by microbiome dysbiosis. They develop proprietary digestion-resistant carbohydrates, specifically maltosyl-isomaltooligosaccharide (MIMO), to target beneficial bacteria and correct dysbiosis. Their lead asset, ISOT-101, is... Read More
